These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9069553)

  • 21. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
    Zaman MM; Landman D; Burney S; Quale JM
    J Antimicrob Chemother; 1996 Jan; 37(1):127-32. PubMed ID: 8647753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin.
    Cohen MA; Huband MD; Gage JW; Yoder SL; Roland GE; Gracheck SJ
    J Antimicrob Chemother; 1997 Aug; 40(2):205-11. PubMed ID: 9301985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.
    Ford AS; Baltch AL; Smith RP; Ritz W
    J Antimicrob Chemother; 1993 Apr; 31(4):523-32. PubMed ID: 8390434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
    Thabet L; Memmi M; Turki A; Messadi AA
    Tunis Med; 2010 May; 88(5):297-300. PubMed ID: 20517823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
    Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
    J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
    Allemandi DA; Alovero FL; Manzo RH
    J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital.
    Cook PP; Catrou P; Gooch M; Holbert D
    J Hosp Infect; 2006 Dec; 64(4):348-51. PubMed ID: 17046104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of animal models in evaluation of the quinolones.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Rev Infect Dis; 1988; 10 Suppl 1():S113-6. PubMed ID: 3279487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Willcox MD
    Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A
    J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methicillin-resistant Staphylococcus aureus (MRSA) -- case report].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):581; quiz 589-92. PubMed ID: 15761786
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus.
    Bosso JA; Mauldin PD
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2106-12. PubMed ID: 16723572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
    Coskun-Ari FF; Bosgelmez-Tinaz G
    Eur J Med Res; 2008 Aug; 13(8):366-70. PubMed ID: 18952518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.